Mevalonic acid

Mevalonic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 10134 references associated with Mevalonic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Mevalonic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Mevalonic acid

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Leukemia D007938 74 associated lipids
Per page 10 20 50 | Total 25

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Mevalonic acid

Download all related citations
Per page 10 20 50 100 | Total 2899
Authors Title Published Journal PubMed Link
Kobayashi Y et al. Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. 2015 Clin. Cancer Res. pmid:26109099
Schwarz BH et al. Kinetic characterization of an oxidative, cooperative HMG-CoA reductase from Burkholderia cenocepacia. 2014 Biochim. Biophys. Acta pmid:24316250
Hamid PH et al. Differential inhibition of host cell cholesterol de novo biosynthesis and processing abrogates Eimeria bovis intracellular development. 2014 Parasitol. Res. pmid:25199551
Pandyra A et al. Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop. 2014 Cancer Res. pmid:24994712
Kanugula AK et al. Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms. 2014 FEBS J. pmid:24964743
Workalemahu G et al. Metabolic engineering of Salmonella vaccine bacteria to boost human Vγ2Vδ2 T cell immunity. 2014 J. Immunol. pmid:24943221
Ranji P et al. Loss of HMG-CoA reductase in C. elegans causes defects in protein prenylation and muscle mitochondria. 2014 PLoS ONE pmid:24918786
Vinokur JM et al. Evidence of a novel mevalonate pathway in archaea. 2014 Biochemistry pmid:24914732
Pampalakis G et al. The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway. 2014 Oncotarget pmid:24158494
Bentley FK et al. Heterologous expression of the mevalonic acid pathway in cyanobacteria enhances endogenous carbon partitioning to isoprene. 2014 Mol Plant pmid:24157609